Illinois Neurofibromatosis Inc is categorized under Social Service and Welfare Organizations in Lombard, IL and active since 1982.
Illinois Neurofibromatosis Inc was established in 1982, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Social Service and Welfare Organizations business, which does work in the B2C market, and is classified as a Social Service and Welfare Organizations, under code number 624190 by the NAICS.
If you are seeking more information, feel free to contact Diana Haberkant at the company’s single location by writing to 145 South Main St Office, Lombard, Illinois IL 60148 or by phoning (630) 932-8111. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Illinois Neurofibromatosis Inc |
| Contact Person: | Diana Haberkant |
| Address: | 145 South Main St Office, Lombard, Illinois 60148 |
| Phone Number: | (630) 932-8111 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1982 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Social Service and Welfare Organizations |
| SIC Code: | 8322 |
| NAICS Code: | 624190 |
| Share This Business: |
Illinois Neurofibromatosis Inc was started in 1982 to provide professional Social Service and Welfare Organizations under the SIC code 8322 and NAICS code 624190. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Diana Haberkant for inquiries that concern Illinois Neurofibromatosis Inc by calling the company number (630) 932-8111, as your correspondence is most welcome. Additionally, the physical location of the single location of Illinois Neurofibromatosis Inc can be found at the coordinates as well as the street address 145 South Main St Office in Lombard, Illinois 60148.
For its online presence, you may visit Illinois Neurofibromatosis Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.